Clinical Trial Update: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating withdrawal of disease-modifying therapies in inactive secondary progressive multiple sclerosis patients over 50 years old.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Snippet

Sponsor: Rennes University Hospital | Conditions: Multiple Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING